Market capitalisation, EUR | 207,270.39 m |
EPS, EUR | 6.84 |
P/B ratio | 5.27 |
P/E ratio | 13.83 |
Dividend yield | 3.12% |
Revenue, EUR | 42,031.24 m |
Net income, EUR | 7,925.26 m |
Profit margin | 18.86% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
First Trust Value Line® Dividend Index UCITS ETF Acc | 0.56% | Equity United States Dividend | 175 | 0.70% | 18 | +7.77% | A2PZMV | IE00BKVKW020 |
L&G Pharma Breakthrough UCITS ETF | 2.23% | Equity World Health Care Innovation | 43 | 0.49% | 18 | -15.76% | A2H9XR | IE00BF0H7608 |
YTD | +2.16% |
1 month | +7.99% |
3 months | +1.62% |
6 months | +6.07% |
1 year | -0.46% |
3 years | +28.01% |
5 years | - |
Since inception (MAX) | +15.30% |
2023 | +4.16% |
2022 | +16.57% |
2021 | - |
2020 | - |
Volatility 1 year | 17.69% |
Volatility 3 years | 18.49% |
Volatility 5 years | - |
Return per risk 1 year | -0.03 |
Return per risk 3 years | 0.46 |
Return per risk 5 years | - |
Maximum drawdown 1 year | -12.83% |
Maximum drawdown 3 years | -14.51% |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -14.67% |